Symbol
STOK on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock
Latest Disclosed Ownership
2.74M shares
Security Ownership
5.1%

BlackRock Portfolio Management LLC ownership in Stoke Therapeutics, Inc. Common Stock (STOK)

2025-04-15 - BlackRock Portfolio Management LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.74M shares of Stoke Therapeutics, Inc. Common Stock (STOK). This represents 5.1% percent ownership of the company.